'
Advanced Enzymes Technologies conducted conference call on 12 February 2025 to discuss the financial results and performance of the company for the quarter ended December 2024. Mr. Mukund Kabra – Whole-time Director and Mr. Beni Prasad Rauka - Chief Financial Officer along with other senior management of the company addressed the call
Highlights of the Concall
- Revenue increased 5.08% to Rs 169.11 crore in Q3FY25 compared to Q3FY24. The company recognized additional sales of Rs 8 crore which the company was not able to recognize in Q2 since revenue recognition criteria was not made as per the accounting standard.
- Human nutrition segment contributed to 60% of total sales in Q3FY25 and decreased by 8% to Rs 101.8 crore in Q3FY25 as compared to Rs 110.7 crore in Q3FY24.
- Animal nutrition contributed to 12% of total sales in Q3FY25 and delivered a growth of 22% to Rs 19.7 crore compared to Q3FY24
- Bio-processing segment contri...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|